1 Product identity
Ingredient risk
1 ingredient to use with caution
Artriphen
BrandXYMOGEN EP→Other Combinations Capsule 15 ingredients 1 caution DSLD #5921Net contents: 90 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-02-23
2 Ingredients (15)
IngredientGroupSafety
artriphen Proprietary BlendProprietary Blend (Combination)—
Omega 3 Fatty AcidsOmega-3—
HPMCHypromellose—
Microcrystalline CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Selenium — Conditionally Safe
⚠ Selenosis >400 mcg
⚠ Diabetes risk at high doses
Manganese — Conditionally Safe
⚠ Neurotoxicity with chronic excess
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Glucosamine — Limited Evidence
⚠ Shellfish allergy
⚠ May affect glucose
Methylsulfonylmethane — Generally Safe
⚠ GI effects
⚠ Headache
Chondroitin — Limited Evidence
⚠ May enhance anticoagulants
Hyaluronic acid — Generally Safe
⚠ Generally well tolerated
⚠ Theoretical concern in active cancer (promotes angiogenesis)
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID5921
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-02-23
6 More from XYMOGEN EP
View XYMOGEN EP Safety Scorecard → 7 products
Hormone Protecti5 Biotransformation Shake Mix Chocolate MintIgG 2000 CWPOncoPLEXRegeneMaxRegeneMax7 Cite this page
Vancouver
Pkhakadze G. Artriphen — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://supplement.ge/products/dsld-5921/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG